Megalencephalic leukoencephalopathy with subcortical cysts: Chronic white matter oedema due to a defect in brain ion and water homoeostasis

The Lancet Neurology

Volumn 11, Issue 11, 2012, Pages 973-985

  van der Knaap, Marjo S ^a   Boor, Ilja ^a   Estévez, Raúl ^b,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Institute of Neurosciences   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; CELL ADHESION MOLECULE; CHLORIDE CHANNEL; CHLORIDE CHANNEL CLC2; ION; POTASSIUM; PROTEIN GLIALCAM; PROTEIN MLC1; UNCLASSIFIED DRUG;

ASTROCYTE; BRAIN CYST; BRAIN EDEMA; BRAIN WATER; CELL VOLUME; CHRONIC WHITE MATTER OEDEMA; DETERIORATION; GENE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; HEPACAM GENE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; LEUKOENCEPHALOPATHY; MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYST; MLC1 GENE; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 84867594558     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(12)70192-8     Document Type: Review

References (103)

1. Van der Knaap MS, Barth PG, Stroink H, et al. Leukoencephalopathy with swelling and a discrepantly mild clinical course in eight children. Ann Neurol 1995, 37:324-334.
2. Singhal BS, Gursahani RD, Udani VP, Biniwale AA Megalencephalic leukodystrophy in an Asian Indian ethnic group. Pediatr Neurol 1996, 14:291-296.
3. Thelle T, Balslev T, Christenen T Van der Knaap's vacuolating leukoencephalopathy: two additional cases. Eur J Pediatr Neurol 1999, 3:83-86.
4. Gelal F, Call C, Apaydin M, Erdem G Van der Knaap's leukoencephalopathy: report of five new cases with emphasis on diffusion-weighted MRI findings. Neuroradiology 2002, 4:625-630.
5. Saijo H, Nakayama H, Ezoe T, et al. A case of megalencephalic leukoencephalopathy with subcortical cysts (van der Knaap disease): molecular genetic study. Brain Dev 2003, 25:362-366.
6. Van der Knaap MS Forget about "van der Knaap syndrome" AJNR Am J Neuroradiol 2003, 24:1030.
7. Harbord MG, Harden A, Harding B, Brett EM, Baraitser M Megalencephaly with dysmyelination, spasticity, ataxia, seizures and distinctive neurophysiological findings in two siblings. Neuropediatrics 1990, 21:164-168.
8. Yiş U, Scheper GC, Uran N, et al. Two cases with megalencephalic leukoencephalopathy with subcortical cysts and MLC1 mutations in the Turkish population. Turk J Pediatr 2010, 52:179-183.
9. Singhal BS Leukodystrophies: Indian scenario. Indian J Pediatr 2005, 72:315-318.
10. Singhal BS, Gorospe JR, Naidu S Megalencephalic leukoencephalopathy with subcortical cysts. J Child Neurol 2003, 18:646-652.
11. Gorospe JR, Singhal BS, Kainu T, et al. Indian Agarwal megalencephalic leukodystrophy with cysts is caused by a common MLC1 mutation. Neurology 2004, 62:878-882.
12. Van der Knaap MS, Scheper GC Megalencephalic leukoencephalopathy with subcortical cysts. GeneReviews 1993, University of Washington, Seattle, (accessed Aug 23, 2012). http://www.ncbi.nlm.nih.gov/books/NBK1116/, R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens (Eds.).
13. Goutières F, Boulloche J, Bourgeois M, Aicardi J Leukoencephalopathy, megalencephaly, and mild clinical course. A recently individualized familial leukodystrophy. Report on five new cases. J Child Neurol 1996, 11:439-444.
14. Topçu M, Saatci I, Topcuoglu MA, Kose G, Kunak B Megalencephaly and leukodystrophy with mild clinical course: a report on 12 new cases. Brain Dev 1998, 20:142-153.
15. Ben-Zeev B, Gross V, Kushnir T, et al. Vacuolating megalencephalic leukoencephalopathy in 12 Israeli patients. J Child Neurol 2001, 16:93-99.
16. Mejaški-Bošnjak V, Bešenski N, Brockmann K, Pouwels PJW, Frahm J, Hanefeld FA Cystic leukoencephalopathy in a megalencephalic child: clinical and magnetic resonance imaging/magnetic resonance spectroscopy findings. Pediatr Neurol 1997, 16:347-350.
17. Riel-Romero RM, Smith CD, Pettigrew AL Megalencephalic leukoencephalopathy with subcortical cysts in two siblings owing to two novel mutations: case reports and review of the literature. J Child Neurol 2005, 20:230-234.
18. Bugiani M, Moroni I, Bizzi A, et al. Consciousness disturbances in megalencephalic leukoencephalopathy with subcortical cysts. Neuropediatrics 2003, 34:211-214.
19. Pascual-Castroviejo I, van der Knaap MS, Pronk JC, García-Segura JM, Gutiérrez-Molina M, Pascual-Pascual SI Vacuolating megalencephalic leukoencephalopathy: 24 year follow-up of two siblings. Neurologia 2005, 20:33-40.
20. Patrono C, Di Giacinto G, Eymard-Pierre E, et al. Genetic heterogeneity of megalencephalic leukoencephalopathy and subcortical cysts. Neurology 2003, 61:534-537.
21. Van der Knaap, Lai V, Köhler W, et al. Megalencephalic leukoencephalopathy with cysts without MLC1 defect. Ann Neurol 2010, 67:834-837.
22. López-Hernández T, Ridder MC, Montolio M, et al. Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism. Am J Hum Genet 2011, 88:422-432.
23. Robinson RO White matter attenuation and megalencephaly. Arch Dis Child 1985, 60:1079-1081.
24. Yalçinkaya C, Yüksel A, Çomu S, Kiliç G, Çokar Ö, Dervent A Epilepsy in vacuolating megalencephalic leukoencephalopathy with subcortical cysts. Seizure 2003, 12:388-396.
25. De Stefano N, Balestri P, Dotti MT, et al. Severe metabolic abnormalities in the white matter of patients with vacuolating megalencephalic leukoencephalopathy with subcortical cysts. A proton MR spectroscopic imaging study. J Neurol 2001, 248:403-409.
26. Van der Voorn JP, Pouwels PJW, Hart AA, et al. Childhood white matter disorders: quantitative MR imaging and spectroscopy. Radiology 2006, 241:510-517.
27. Brockmann K, Finsterbusch J, Terwey B, Frahm J, Hanefeld F Megalencephalic leukoencephalopathy with subcortical cysts in an adult: quantitative proton MR spectroscopy and diffusion tensor MRI. Neuroradiology 2003, 45:137-142.
28. Van der Knaap, Barth PG, Vrensen GFJM, Valk J Histopathology of an infantile-onset spongiform leukoencephalopathy with a discrepantly mild clinical course. Acta Neuropathol 1996, 92:206-212.
29. Miles L, Degrauw TJ, Dinopoulos A, Cecil KM, van der Knaap MS, Bove KE Megalencephalic leukoencephalopathy with subcortical cysts (MLC): a third confirmed case with literature review. Pediatr Dev Pathol 2009, 12:180-186.
30. Duarri A, Lopez de Heredia M, Capdevila-Nortes X, et al. Knockdown of MLC1 in primary astrocytes causes cell vacuolation: a MLC disease cell model. Neurobiol Dis 2011, 43:228-238.
31. Topçu M, Gartioux C, Ribierre F, et al. Vacuoliting megalencephalic leukoencephalopathy with subcortical cysts, mapped to chromosome 22qtel. Am J Hum Genet 2000, 66:733-739.
32. Leegwater PA, Yuan BQ, van der Steen J, et al. Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts. Am J Hum Genet 2001, 68:831-838.
33. Leegwater PAJ, Boor PKI, Yuan BQ, et al. Identifications of novel mutations in MLC1 responsible for megalencephalic leukoencephalopathy with subcortical cysts. Hum Genet 2002, 110:279-283.
34. Shukla P, Gupta N, Ghosh M, et al. Molecular genetic studies in Indian patients with megalencephalic leukoencephalopathy. Pediatr Neurol 2011, 44:450-458.
35. Ben-Zeev B, Levy-Nissenbaum E, Lahat H, et al. Megalencephalic leukoencephalopathy with subcortical cysts; a founder effect in Israeli patients and a higher than expected carrier rate among Libyan Jews. Hum Genet 2002, 111:214-218.
36. Koussa S, Roukoz H, Rizk T, Mégarbané A Megalencephalic leucoencephalopathy with subcortical cysts: a study of a Lebanese family and a review of the literature. Rev Neurol (Paris) 2005, 161:183-191.
37. Tsujino S, Kanazawa N, Yoneyama H, et al. A common mutation and a novel mutation in Japanese patients with van der Knaap disease. J Hum Genet 2003, 48:605-608.
38. Boor I, de Groot K, Mejaski-Bosnjak V, et al. Megalencephalic leukoencephalopathy with subcortical cysts: an update and extended mutation analysis of MLC1. Hum Mutat 2006, 27:505-512.
39. Montagna G, Teijido O, Eymard-Pierre E, et al. Vacuolating megalencephalic leukoencephalopathy with subcortical cysts: functional studies of novel variants in MLC1. Hum Mutat 2006, 27:292.
40. Blattner R, Von Moers A, Leegwater PA, Hanefeld FA, Van Der Knaap MS, Köhler W Clinical and genetic heterogeneity in megalencephalic leukoencephalopathy with subcortical cysts (MLC). Neuropediatrics 2003, 34:215-218.
41. Scheper GC, van Berkel CG, Leisle L, et al. Analysis of CLCN2 as candidate gene for megalencephalic leukoencephalopathy with subcortical cysts. Genet Test Mol Biomarkers 2010, 14:255-257.
42. Meyer J, Huberth A, Ortega G, et al. A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree. Mol Psychiatry 2001, 6:302-306.
43. Devaney JM, Donarum EA, Brown KM, et al. No missense mutation of WKL1 in a subgroup of probands with schizophrenia. Mol Psychiatry 2002, 7:419-423.
44. Rubie C, Lichtner P, Gärtner J, et al. Sequence diversity of KIAA0027/MLC1: are megalencephalic leukoencephalopathy and schizophrenia allelic disorders?. Hum Mutat 2002, 21:45-52.
45. McQuillin A, Kalsi G, Moorey H, et al. A novel polymorphism in exon 11 of the WKL1 gene, shows no association with schizophrenia. Eur J Hum Genet 2002, 10:491-494.
46. Kaganovich M, Peretz A, Ritsner M, Bening Abu-Shach U, Attali B, Navon R Is the WKL1 gene associated with schizophrenia?. Am J Med Genet B Neuropsychiatr Genet 2004, 125B:31-37.
47. Verma R, Mukerji M, Grover D, et al. MLC1 gene is associated with schizophrenia and bipolar disorder in Southern India. Biol Psychiatry 2005, 58:16-22.
48. Selch S, Strobel A, Haderlein J, et al. MLC1 polymorphisms are specifically associated with periodic catatonia, a subgroup of chronic schizophrenia. Biol Psychiatry 2007, 61:1211-1214.
49. Spijker S, Van Zanten JS, De Jong S, et al. Stimulated gene expression profiles as a blood marker of major depressive disorder. Biol Psychiatry 2010, 68:179-186.
50. Boor PKI, de Groot K, Waisfisz Q, et al. MLC1: a novel protein in distal astroglial processes. J Neuropathol Exp Neurol 2005, 64:412-419.
51. Nomura N, Miyajima N, Sazuka T, et al. Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. DNA Res 1994, 1:27-35.
52. Ridder MC, Boor I, Lodder JC, et al. Megalencephalic leucoencephalopathy with cysts: defect in chloride currents and cell volume regulation. Brain 2011, 134:3342-3354.
53. Teijido O, Martinez A, Pusch M, et al. Localization and functional analyses of the MLC1 protein involved in megalencephalic leukoencephalopathy with subcortical cysts. Hum Mol Genet 2004, 13:2581-2594.
54. Schmitt A, Gofferje V, Weber M, Meyer J, Mössner R, Lesch KP The brain-specific protein MLC1 implicated in megalencephalic leukoencephalopathy with subcortical cysts is expressed in glial cells in the murine brain. Glia 2003, 44:283-295.
55. Boor I, Nagtegaal M, Kamphorst W, et al. MLC1 is associated with the dystrophin-glycoprotein complex at astrocytic endfeet. Acta Neuropathol 2007, 114:403-410.
56. van der Knaap MS, Smit LM, Barth PG, et al. Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. Ann Neurol 1997, 42:50-59.
57. Culligan K, Ohlendieck K Diversity of the brain dystrophin-glycoprotein complex. J Biomed Biotechnol 2002, 2:31-36.
58. Ambrosini E, Serafini B, Lanciotti A, et al. Biochemical characterization of MLC1 protein in astrocytes and its association with the dystrophin-glycoprotein complex. Mol Cell Neurosci 2008, 37:480-493.
59. Teijido O, Casaroli-Marano R, Kharkovets T, et al. Expression patterns of MLC1 protein in the central and peripheral nervous systems. Neurobiol Dis 2007, 26:532-545.
60. Benfenati V, Ferroni S Water transport between CNS compartments: functional and molecular interactions between aquaporins and ion channels. Neuroscience 2010, 168:926-940.
61. Benfenati V, Nicchia GP, Svelto M, Rapisarda C, Frigeri A, Ferroni S Functional down-regulation of volume-regulated anion channels in AQP4 knockdown cultured rat cortical astrocytes. J Neurochem 2007, 100:87-104.
62. Nedergaard M, Dirnagl U Role of glial cells in cerebral ischemia. Glia 2005, 50:281-286.
63. Simard M, Nedergaard M The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 2004, 129:877-896.
64. Pasantes-Morales H, Lezama RA, Ramos-Mandujano G, Tuz KL Mechanisms of cell volume regulation in hypo-osmolality. Am J Med 2006, 119:S4-11.
65. Mulligan SJ, MacVicar BA VRACs CARVe a path for novel mechanisms of communication in the CNS. Sci STKE 2006, 357:pe42.
66. Stutzin A, Hoffmann EK Swelling-activated ion channels: functional regulation in cell-swelling, proliferation and apoptosis. Acta Physiol (Oxf) 2006, 187:27-42.
67. Jentsch TJ, Stein V, Weinreich F, Zdebik AA Molecular structure and physiological function of chloride channels. Physiol Rev 2002, 82:503-568.
68. Nilius B, Droogmans G Amazing chloride channels: an overview. Acta Physiol Scand 2003, 177:119-147.
69. - currents in cultured rat astrocytes. J Physiol 2006, 572:677-689.
70. Lascola CD, Kraig RP Whole-cell chloride currents in rat astrocytes accompany changes in cell morphology. J Neurosci 1996, 16:2532-2545.
71. Brignone MS, Lanciotti A, Macioce P, et al. The beta1 subunit of the Na,K-ATPase pump interacts with megalencephalic leucoencephalopathy with subcortical cysts protein 1 (MLC1) in brain astrocytes: new insights into MLC pathogenesis. Hum Mol Genet 2011, 20:90-103.
72. Lanciotti A, Brignone MS, Molinari P, et al. Megalencephalic leukoencephalopathy with subcortical cysts protein 1 functionally cooperates with the TRPV4 cation channel to activate the response of astrocytes to osmotic stress: dysregulation by pathological mutations. Hum Mol Genet 2012, 21:2166-2180.
73. Becker D, Blase C, Bereiter-Hahn J, Jendrach M TRPV4 exhibits a functional role in cell-volume regulation. J Cell Sci 2005, 118:2435-2440.
74. Moh MC, Lee LH, Shen S Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma. J Hepatol 2005, 42:833-841.
75. Favre-Kontula L, Rolland A, Bernasconi L, et al. GlialCAM, an immunoglobulin-like cell adhesion molecule is expressed in glial cells of the central nervous system. Glia 2008, 56:633-645.
76. Edelman GM Cell adhesion molecules in the regulation of animal form and tissue pattern. Annu Rev Cell Biol 1986, 2:81-116.
77. Rosales C, O'Brien V, Kornberg L, Juliano R Signal transduction by cell adhesion receptors. Biochim Biophys Acta 1995, 1242:77-98.
78. Sakisaka T, Takai Y Cell adhesion molecules in the CNS. J Cell Sci 2005, 118:5407-5410.
79. Fox MA, Umemori H Seeking long-term relationship: axon and target communicate to organize synaptic differentiation. J Neurochem 2006, 97:1215-1231.
80. Dityatev A, Dityateva G, Sytnyk V, et al. Polysialylated neural cell adhesion molecule promotes remodeling and formation of hippocampal synapses. J Neurosci 2004, 24:9372-9382.
81. Maness PF, Schachner M Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat Neurosci 2007, 10:19-26.
82. Lanciotti A, Brignone MS, Camerini S, et al. MLC1 trafficking and membrane expression in astrocytes: role of caveolin-1 and phosphorylation. Neurobiol Dis 2010, 37:581-595.
83. Moh MC, Lee LH, Zhang T, Shen S Interaction of the immunoglobulin-like cell adhesion molecule hepaCAM with caveolin-1. Biochem Biophys Res Comm 2009, 378:755-760.
84. Sowa G Caveolae, caveolins, cavins, and endothelial cell function: new insights. Front Physiol 2012, 2:1-13.
85. Zhang QL, Luo CL, Wu XH, et al. HepaCAM induces G1 phase arrest and promotes c-Myc degradation in human renal cell carcinoma. J Cell Biochem 2011, 112:2910-2919.
86. Xun C, Luo C, Wu X, Zhang Q, Yan L, Shen S Expression of hepaCAM and its effect on proliferation of tumor cells in renal cell carcinoma. Urology 2010, 75:828-834.
87. Lee LH, Moh MC, Zhang T, Shen S The immunoglobulin-like cell adhesion molecule hepaCAM induces differentiation of human glioblastoma U373-MG cells. J Cell Biochem 2009, 107:1129-1138.
88. López-Hernández T, Sirisi S, Capdevila-Nortes X, et al. Molecular mechanisms of MLC1 and GLIALCAM mutations in megalencephalic leukoencephalopathy with subcortical cysts. Hum Mol Genet 2011, 20:3266-3277.
89. Jentsch TJ, Poet M, Fuhrmann JC, Zdebik AA Physiological functions of CLC Cl- channels gleaned from human genetic disease and mouse models. Annu Rev Physiol 2005, 67:779-807.
90. - channel auxiliary subunit. Neuron 2012, 5:951-961.
91. Blanz J, Schweizer M, Auberson M, et al. Leukoencephalopathy upon disruption of the chloride channel ClC-2. J Neurosci 2007, 27:6581-6589.
92. Bösl MR, Stein V, Hubner C, et al. Male germ cells and photoreceptors, both dependent on close cell-cell interactions, degenerate upon ClC-2 Cl(-) channel disruption. EMBO J 2001, 20:1289-1299.
93. Edwards M, Marín de Evsikova C, Collin GB, et al. Photoreceptor degeneration, azoospermia, leukoencephalopathy, and abnormal RPE cell function in mice expressing an early stop mutation in CLCN2. Invest Ophthalmol Vis Sci 2010, 51:3264-3272.
94. Thiemann A, Grunder S, Pusch M, Jentsch TJ A chloride channel widely expressed in epithelial and non-epithelial cells. Nature 1992, 356:57-60.
95. Duarri A, Teijido O, López-Hernández T, et al. Molecular pathogenesis of megalencephalic leukoencephalopathy with subcortical cysts: mutations in MLC1 cause folding defects. Hum Mol Genet 2008, 17:3728-3739.
96. Moh MC, Zhang C, Luo C, Lee LH, Shen S Structural and functional analyses of a novel Ig-like cell adhesion molecule, hepaCAM, in the human breast carcinoma MCF7 cells. J Biol Chem 2005, 280:27366-27374.
97. Nagelhus EA, Mathiisen TM, Ottersen OP Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1. Neuroscience 2004, 129:905-913.
98. Rash JE Molecular disruptions of the panglial syncytium block potassium siphoning and axonal saltatory conduction: pertinence to neuromyelitis optica and other demyelinating diseases of the central nervous system. Neuroscience 2010, 168:982-1008.
99. Neusch C, Rozengurt N, Jacobs RE, Lester HA, Kofuji P Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination. J Neurosci 2001, 21:5429-5438.
100. Menichella DM, Majdan M, Awatramani R, et al. Genetic and physiological evidence that oligodendrocyte gap junctions contribute to spatial buffering of potassium released during neuronal activity. J Neurosci 2006, 26:10984-10991.
101. Van der Knaap MS, Valk J Magnetic resonance of myelination and myelin disorders 2005, Springer, Heidelberg.
102. Paulson HL, Garbern JY, Hoban TF, et al. Transient central nervous system white matter abnormality in X-linked Charcot-Marie-Tooth disease. Ann Neurol 2002, 52:429-434.
103. Renaud DL Leukoencephalopathies associated with macrocephaly. Semin Neurol 2012, 32:34-41.